• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
14.01.2025
Tezos Is Seen Hodling above $1.200

Tezos (XTZ) has declined slightly by 0.2% this week, trading at $1.249, following Bitcoin’s (BTC) drop to $89,158, which triggered widespread altcoin sell-offs due to concerns of a potential further decline in BTC to $80,000. However, Bitcoin managed to hold above the critical support level at $89,000-$91,000, offering some relief to the broader crypto market.

Speculation about a shift in U.S. trade policy has provided additional support to crypto assets. Reports suggest the new U.S. administration may pursue a gradual increase in tariffs rather than an abrupt hike, which could help alleviate inflationary pressures and lead to a less aggressive monetary stance from the Federal Reserve.

This development is a positive signal for the cryptocurrency market and may help Tezos maintain its position above the key support level of $1.200.

09.01.2025
VeChain Is Suffering on Rising Borrowing Costs

VeChain (VET) has fallen 12.7% this week, trading at $0.0445, underperforming the broader cryptocurrency market. Bitcoin (BTC), the leading cryptocurrency, has declined by 5.6% to $93,220, with bearish momentum building as it approaches key support at $89,000-$91,000. This decline is largely attributed to tightening monetary conditions in the United States, which continue to weigh on risk assets. Investor confidence is further shaken by significant net outflows from spot BTC-ETFs, which lost $583 million on Wednesday, marking the second-largest single-day outflow on record.

If BTC falls below the critical support level of $89,000-$91,000, VeChain is likely to extend its losses, with prices potentially declining another 10% to $0.0400. A sustained drop in BTC could push VET even lower, towards $0.0300. Conversely, a strong rebound in BTC prices to the $100,000 level could drive VET back up to $0.0500, representing a recovery of approximately 12% from current levels.

20.01.2025
Investment Banks Are Ahead of Lenders

An advance guard of the U.S. banking segment has reported for the ending quarter of 2024 ahead of the corporate earnings season's major chapters, which are still coming in and are supposed to make an overall positive contribution. But what's interesting is, the variety of lending institutions performed a solid organic growth in terms of both revenue and pure income, while the essentially investment giants like Goldman Sachs (GS) and BlackRock (BLK) grew up on a much firmer foundation. There is an impression that well-organised asset management, based on proper contextual ad hoc and mid-term stock transactions, is still producing enhanced results when compared to the returns of somewhat shabby loan portfolios at still quite heavy interest rates.

A temporary increase in Blackrock market value was up to 6.5% at its highest intraday point on January 15, following its record ever $11.93 of equity per share (EPS) on an also absolutely highest number of $5.68 billion in quarterly sales. Blackrock's three-month achievements provided a 23.5% annual boost in EPS vs nearly14% expected at EPS of $11.06 per share, which was supposed in analyst pool projections in reputable news outlets like Bloomberg and Reuters. Many investment houses quickly adjusted their price target areas for Blackrock shares, while also keeping Outperform ratings on the stock. As an example, Keefe, Bruyette & Woods (KBW) revised its price goal for Blackrock to $1,180, citing the investment bank's diversified inflows and global expansion growth initiatives which made the company favorably positioning in the eyes of analysts and investors alike. Blackrock is currently traded around $1000 per share.

However, the Goldman Sachs (GS) effect even surpassed the previous case, with an emergence of totally new peaks above $625 on GS charts, where the shares of this widely recognized investment giant had never been before. The weekly gain was more than 11.5% from $560 per share at the closing price on January 10. Goldman Sachs provided last quarter's EPS at $11.95 per share, beating a $8.12 consensus forecast, with its revenue achieving as high as $13.87 billion vs $12.15 billion previously estimated on average. This means that GS net revenues are up 7% YoY but its adjusted income soared by 54%, so that the firm maintains its clear leadership in global investment banking, including merge and acquisition advisory and wealth management services. Such a strong kind of resilience revived inner projections for EPS of $47.50 for fiscal year 2025 and $52.50 for fiscal year 2026. Isn't this a ready-made reason for targets above $650, or even $700 per share in the coming months, or at least before the end of 2025? By the way, Goldman Sachs CEO David Solomon was freshly rewarded by an $80 million stock bonus to stay at the helm for another 5 years, and John Waldron, a chief operating officer who is seen by many as a successor to Solomon, who is 63 now, was also awarded with his retention bonus of the same $80 million in restricted stock. However, the huge crowd of Goldman Sachs investors on Wall Street is hardly feeling offended or sad either, given the stock's crazy growth pace by the banking segment's standards.

The very fact that a cycle of lower borrowing rates has started in 2024 on both sides of the pond is helping the banking environment tremendously, which may in turn expand into a real business so soon, but the process may be happening more slowly than many Wall Street inhabitants would like to see due to a pause in the dovish shift by the Federal Reserve and other financial regulators. Wells Fargo (WFC), which also has an increasingly advanced investment focus among its recovering lending business, gained more than 8% since last week's earnings' report, coming very close to all-time peaks around $78 per share. Shares of JPMorgan Chase (JPM) and Morgan Stanley (MS) also broke their previous price records, but gained within 5% and 7%, while the Bank of America (BAC) failed to add more than 2% for the reporting week, while its quarterly profits and sales were high but still within its previous lofty standards. The smaller part of investment business versus the credit component for the last three banks mentioned above seems like a reasonable justification for this tendency.

14.01.2025
Merck Becomes Interesting to Be Added to a Portfolio

Merck & Co (MRK) stocks have shown signs of becoming a compelling buy opportunity. Over the past six months, the stock has been in a downtrend, declining 29.8% to $94.50 per share. However, since mid-November, MRK has demonstrated a reversal of momentum, rebounding by 10.0% to reach $104.87 on December 5. Following a brief pullback and consolidation period, the stock has retested the downtrend resistance and appears poised to continue its upward trajectory.

With prices currently positioned to target $110.00, this represents a potential 9-10% upside from the present levels. Setting a stop-loss at $93.50 aligns with a prudent risk management strategy, providing protection against further downside while allowing for upside potential. The recent consolidation phase further supports the case for a breakout, making this an attractive moment to consider initiating or adding to a position in MRK.

16.01.2025
Delta Is Taking Off To Update Its Highs

Delta Air Lines stock rose markedly by low double digits in the first ten days of the new year. The U.S. carrier has served more than 200 million customers in 2024, when it was also recognized by J.D. Power, a leading American data analytics and consumer intelligence company, for being No. 1 in First/Business and Premium Economy Passenger Satisfaction. Travelers became more willing to spend extra money for swanky seats when meeting a high level of service. Delta is just positioning itself as the nation's premium airline. And what's more important, its Christmas quarter's earnings reportedly surpassed average analyst pool projections. Driven by stronger travel demand, smart financial management and capacity discipline, Delta business provided last three-months' profit of $1.85 per share vs $1.28 at the same period one year ago, compared to $1.75 in consensus estimates. On January 10, the airline industry leader put its future profit levels within a range between $0.70 and $1 per share in the current quarter through the end of March, while analyst expectations were focused on $0.77 cents, according to data compiled by LSEG. The starting months of each year always perform worse. It is clear that all carriers made losses in the Covid years of 2020-2022, but Delta profits only recovered into a range from $0.25 to $0.45 in the first quarter of 2023 and 2024, respectively, but Q1 profit numbers varied from $0.75 to $0.96 even in the three blessed years before the pandemic. Delta added that it is forecasting annual earnings in excess of $7.35 a share, which would be the highest in its 100-year history, based on its planned revenue growth of 7% to 9% in the March quarter from a year ago. The announcement could be compared to an adjusted profit of $6.16 a share in 2024. The company happily breaks through ticket prices' rising effects, almost undisturbed by a reduction in airline seats in the domestic market, which was peculiar for most carriers. Thus, new expectations created a fertile ground for setting new price records, even though price movements on Delta charts look most convincing among its other American rivals.

By the way, Citigroup analysts freshly updated their outlook on Delta Air Lines shares to raise their price target to $80 from the previous $77, vs the actual range around $65 per share where the stock just came after a reasonable market correction from last week's and all-time highs. Citigroup said it has included factors like higher revenue per available seat mile, projections of slightly lower fuel prices, increased taxation, a minor rise in share count, and the incorporation of fourth-quarter 2024 results into their financial model, which has projected Delta's profit at $7.49 per share in 2024 and $8.72 in 2025. Delta shares are Buy-rated at Citi, and we agree with their positive estimates in general, while keeping in mind even better price goals somewhere between $82.5 and $85.

Another Good Chance to Buy Merck

Merck share price partially used a fresh upside momentum to stop less than half of a dollar below the next $135 psychological resistance. U.S. Food and Drug Administration (FDA), which has approved KEYTRUDA, Merck’s anticancer drug (acting as an immune checkpoint inhibitor to help keeping T-cells from killing other cells) in combination with two other medications called carboplatin and paclitaxel, for the treatment of adult patients with primary advanced or recurrent endometrial carcinoma. It has been reported that KEYTRUDA plus carboplatin and paclitaxel followed by KEYTRUDA alone reduced the risk of disease progression or death by 40% for patients, whose cancer was mismatch repair proficient and by 70% for the group of patients, whose cancer was mismatch repair deficient when compared to placebo with carboplatin and paclitaxel followed by placebo alone.

Thus, this approval is based on data from the Phase 3 trial, being the third endometrial indication and the 40th indication overall for KEYTRUDA in North America. Hitting all-time peak at $134.62 on June 25 was followed by some further price retracement to nearly $127 during the next couple of trading sessions, which looks like a quite natural phenomenon on the market when the price just slightly exceeded the previous technical range. Yet, the bullish pressure quickly renewed, as soon as Merck price just started to bounce, so that it closed at as high as $129.82 on June 27. Any levels between $127 and $130 per share may represent another good chance to buy stocks by investing crowds, with only a tiny likelihood for the price to dive below $125.

We anticipated one more bullish stage in Merck stock since the beginning of the year, when the share price of the world's oldest pharmaceutical concern was hovering below $120. It has already moved to a higher price and now fundamental conditions are looking good for the next evolutionary transition path. So, every other technical call to action to buy Merck may lead its share price closer to Wall Street's analyst pool 12-month target, which is located at nearly $142.70, but may be easily moved to higher levels above $150 at least.

4161
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
ETC is Struggling to Reverse to the Upside

Ethereum Classic (ETC) is experiencing a rise of 2.4% this week, reaching $23.40. This increase comes after a dip of 6.0% to $21.49 on Monday. Currently, ETC is attempting to surpass the $25.00 support level. If a breakthrough above this level is successful, the token could resume its upward trend, targeting the $30.00 resistance.

A significant potential catalyst for ETC prices is the anticipated approval of a spot Ethereum-ETF by the U.S. Securities and Exchange Commission (SEC). Such approval could have a positive impact on ETC prices, contributing to a bullish momentum.

3743
B
Google's Next Stop at $215 or $220?

I doubled my number of Google shares in the end of March when its price crossed a psychological resistance line at $150 per share, while keeping in mind my first target around $175. Today we happily celebrate touching $185 per share already. The AI rally creates wonders, and Google brand is now leading "in AI mindshare among consumers", Jefferies investment house wrote today. It happened so that 63% of all its surveyed consumers associated Google with AI technology. This percentage number is running surprisingly well ahead of OpenAI (51%), Meta Platforms (44%), and Microsoft (28%). Roughly 1,500 consumers were polled by the firm.

The survey revealed that Google’s AI-powered search appealed to so many ordinary users compared to traditional search results. In particular, 41% of respondents voiced a positive reaction compared to 29% who didn’t like new Google's features. 60% of consumers said they are "very or somewhat likely" to use a non-Google AI platform for search. For "at-work use", OpenAI remains a leader, with 27% of workers using its ChatGPT and DALL-E text-to-image models, well above Google at 15%, and Microsoft’s Bing at 14%. Yet, Microsoft is OpenAI's closest, and, of course, "non-commercial" partner, and so shares of Microsoft are also hitting the skies.

Meanwhile, the survey prompted Jefferies to lift their price target on Google-parent Alphabet stock from $200 to $215 this week. I am going to hold my Google at least until hitting $215. Commerzbank is even more optimistic when raising its target to $220, still recommending the stock as a Strong Buy. Its analysts emphasised "the dynamic development and stable growth potential", as Google created a basis for long-term "real-time experiences" by integrating AI modules "into its wide range of products, including Google Search, YouTube, Google Cloud, and Android smartphones". Well, I just totally agree.

4509
FedEx Is Getting Back Into the Race

The U.S. shipping giant experienced long lingering effects of a moderate weakness in previous global trade estimates, which prevented the logistics company's shares from keeping their price at its heights during the next three months after surging to $290+ in mid-March. Further retracement led the stock to below $250. Nevertheless, FedEx made a new attempt to step out from a temporary suspension between its own sky and earth by adding more than 15% in after-hours trading this Tuesday night, with testing levels around $295 per share for the first time since summer 2021 in the pre-market quotes on June 26. A better-than-feared outlook for the rest of 2024 and for fiscal 2025, as well as FedEx's plans for a $2.5 billion share buyback, helped to improve the market's way of seeing the company's prospects. The official announcement by FedEx management said its EPS (equity per share) range might shift to between $20.00 and $22.00, compared to the midpoint for the next year at $20.85 in consensus forecasts of the Wall Street analyst community. Its CEO Raj Subramaniam marked four consecutive quarters of expanding operating income and margin despite a "challenging revenue environment". Its last quarter's EPS reached $5.41 against $3.86 in the previous three-month period and $4.94 in the same season of 2023, while FedEx sales stood at $22.1 billion, a little above $21.9 billion in the same quarter last year and consensus bets of $22.05 billion on average.

Historically, the revenue peaked at $24.4 billion in the March 1 to May 31 quarter of 2022, yet the company said its "strategic initiatives" like FedEx's DRIVE program aiming at reduced structural costs led to improvements in operating income and margin effectiveness. The company now sees a "low-to-mid single-digit" percent revenue surplus YoY for 2023-2024 through achieving $2.2 billion in permanent cost reductions via its DRIVE program by creating the "world’s most flexible, efficient, and intelligent network". When rivals like United Parcel Service (UPS) are also struggling with slow-growing demand for parcel shipping, FedEx achievements look very solid amid the current environment.

FedEx Ground operating results increased due to higher yield, lower self-insurance costs and growing commercial volume. FedEx Freight improved due to a more effective cost management, with loudly announced plans of further optimization and matching capacity with demand through the closure of seven facilities. Meanwhile, FedEx Express operating results slowed due to lower global yields, which were partially balanced by reduced structural costs and better domestic package yields in the US. The FedEx Express subdivision permanently retired certain aircraft and related engines as part of its fleet modernization program.

These stocks are unlikely to become the new market favorites along with some AI-based techs, yet we may consider refreshing FedEx's all-time highs above $320 per share as the baseline scenario for this year, meaning at least a 12% upside potential, which could be described as a minimum program.

4486
158

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors